Chemed Corporation (FRA:CXM)

Chemed Statistics

Total Valuation

Chemed has a market cap or net worth of EUR 5.34 billion. The enterprise value is 5.35 billion.

Market Cap	5.34B
Enterprise Value	5.35B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	Nov 17, 2025

Share Statistics

Current Share Class	14.11M
Shares Outstanding	n/a
Shares Change (YoY)	-3.57%
Shares Change (QoQ)	-2.00%
Owned by Insiders (%)	1.54%
Owned by Institutions (%)	100.18%
Float	13.88M

Valuation Ratios

The trailing PE ratio is 22.49 and the forward PE ratio is 17.37.

PE Ratio	22.49
Forward PE	17.37
PS Ratio	2.48
PB Ratio	5.82
P/TBV Ratio	19.31
P/FCF Ratio	17.40
P/OCF Ratio	14.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.96, with an EV/FCF ratio of 17.43.

EV / Earnings	22.53
EV / Sales	2.45
EV / EBITDA	12.96
EV / EBIT	17.64
EV / FCF	17.43

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.13.

Current Ratio	1.35
Quick Ratio	1.18
Debt / Equity	0.13
Debt / EBITDA	0.30
Debt / FCF	0.39
Interest Coverage	203.68

Financial Efficiency

Return on equity (ROE) is 24.11% and return on invested capital (ROIC) is 16.91%.

Return on Equity (ROE)	24.11%
Return on Assets (ROA)	12.97%
Return on Invested Capital (ROIC)	16.91%
Return on Capital Employed (ROCE)	26.43%
Revenue Per Employee	137,423
Profits Per Employee	15,140
Employee Count	15,695
Asset Turnover	1.49
Inventory Turnover	187.30

Taxes

In the past 12 months, Chemed has paid 78.11 million in taxes.

Income Tax	78.11M
Effective Tax Rate	24.74%

Stock Price Statistics

The stock price has decreased by -31.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.01%
50-Day Moving Average	375.68
200-Day Moving Average	441.58
Relative Strength Index (RSI)	52.28
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.64

Income Statement

In the last 12 months, Chemed had revenue of EUR 2.16 billion and earned 237.63 million in profits. Earnings per share was 16.15.

Revenue	2.16B
Gross Profit	709.23M
Operating Income	299.97M
Pretax Income	315.74M
Net Income	237.63M
EBITDA	351.14M
EBIT	299.97M
Earnings Per Share (EPS)	16.15

Balance Sheet

The company has 110.59 million in cash and 120.58 million in debt, giving a net cash position of -9.99 million.

Cash & Cash Equivalents	110.59M
Total Debt	120.58M
Net Cash	-9.99M
Net Cash Per Share	n/a
Equity (Book Value)	917.66M
Book Value Per Share	65.04
Working Capital	87.96M

Cash Flow

In the last 12 months, operating cash flow was 357.67 million and capital expenditures -50.46 million, giving a free cash flow of 307.21 million.

Operating Cash Flow	357.67M
Capital Expenditures	-50.46M
Free Cash Flow	307.21M
FCF Per Share	n/a

Margins

Gross margin is 32.88%, with operating and profit margins of 13.91% and 11.02%.

Gross Margin	32.88%
Operating Margin	13.91%
Pretax Margin	14.64%
Profit Margin	11.02%
EBITDA Margin	16.28%
EBIT Margin	13.91%
FCF Margin	14.24%

Dividends & Yields

This stock pays an annual dividend of 1.95, which amounts to a dividend yield of 0.52%.

Dividend Per Share	1.95
Dividend Yield	0.52%
Dividend Growth (YoY)	16.79%
Years of Dividend Growth	16
Payout Ratio	11.01%
Buyback Yield	3.57%
Shareholder Yield	4.09%
Earnings Yield	4.45%
FCF Yield	5.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 12, 2005. It was a forward split with a ratio of 2.

Last Split Date	May 12, 2005
Split Type	Forward
Split Ratio	2

Scores

Chemed has an Altman Z-Score of 13.53 and a Piotroski F-Score of 5.

Altman Z-Score	13.53
Piotroski F-Score	5